Tomita Yusuke

トミタユウスケ | Tomita Yusuke

Affiliation and department：

Research field (1)： Respiratory medicine

Research keywords (10)：肺胞蛋白症 , Gut microbiome , SARSーCoVー2 , COVIDー19 , Pharmacodynamics , Interstitial pneumonia , Infectious disease , Immunology , Tumor immunology , Lung Cancer

Research theme for competitive and other funds (3)：

2022 - 2027 Development of a new combinational therapy with immune checkpoint blockade and live biotherapeutic products for advanced lung cancer
2021 - 2024 Development of irAE management strategy based on immuno-senescence, and novel cancer immunotherapy balancing augmented anti-tumor immunity and decreased risk of adverse events
2018 - 2023 進行肺癌を対象とした腫瘍免疫抑制回避と能動免疫を併用するがん免疫療法の臨床研究

Papers (161)：

Moriyasu Anai, Hiroki Inoue, Koichi Saruwatari, Seitaro Oda, Shinya Shiraishi, Kimitaka Akaike, Kosuke Imamura, Takayuki Jodai, Shinya Sakata, Shinji Iyama, et al. Negative-predictive value of SUVmax for Ascertaining the efficacy of osimertinib in EGFR mutation-positive non-small cell lung cancer. Respiratory investigation. 2024. 62. 6. 1072-1078
Kimitaka Akaike, Koichi Saruwatari, Shinya Sakata, Seitaro Oda, Shinya Shiraishi, Shinji Iyama, Aiko Masunaga, Yusuke Tomita, Hidenori Ichiyasu, Takuro Sakagami. ¹⁸F-FDG accumulation at the early onset of acute exacerbation of idiopathic interstitial pneumonia on ¹⁸F-FDG PET/CT: A case report. Respirology Case Reports. 2024. 12. 7
Miki KUROKI, Kimitaka AKAIKE, Seiya NAKASHIMA, Akira TAKAGI, Shinji IYAMA, Aiko MASUNAGA, Yusuke TOMITA, Hidenori ICHIYASU, Takuro SAKAGAMI. Pulmonary Nocardiosis in a Patient with Autoimmune Pulmonary Alveolar Proteinosis that Become Stabilize after Whole-Lung Lavage. Kansenshogaku Zasshi. 2024. 98. 2. 151-155
福嶋一晃, 御任玲美, 猿渡功一, 城臺孝之, 坂田晋也, 猪山慎治, 冨田雄介, 一安秀範, 坂上拓郎. 小細胞肺癌に対するアテゾリズマブ併用化学療法とデュルバルマブ併用化学療法の有効性と安全性の比較検討. 日本呼吸器学会誌. 2024. 13. 増刊. 330-330
Shohei Hamada, Kei Muramoto, Kimitaka Akaike, Hiroko Okabayashi, Aiko Masunaga, Yusuke Tomita, Hidenori Ichiyasu, Takuro Sakagami. The impact of factor Xa inhibitors on bleeding risk in patients with respiratory diseases. Scientific Reports. 2024. 14. 1

ｍore...

MISC (77)：

Chieko Yoshida, Aiko Masunaga, Sho Saeki, Yusuke Tomita, Hidenori Ichiyasu, Takuro Sakagami. Predicting daily physical activity with using 6MWT in patients with chronic interstitial lung diseases. EUROPEAN RESPIRATORY JOURNAL. 2020. 56
Kimitaka Akaike, Koichi Saruwatari, Seitaro Oda, Shohei Hamada, Yusuke Tomita, Sho Saeki, Hidenori Ichiyasu, Kazuhiko Fujii, Shinya Shiraishi, Takuro Sakagami. Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease. EUROPEAN RESPIRATORY JOURNAL. 2019. 54
猿渡功一, 冨田雄介, 佐藤亮, 佐伯祥, 一安秀範, 藤井一彦, 坂上拓郎, 高松孝太郎, 中根俊成. 無症候性抗アセチルコリンレセプター抗体陽性非小細胞肺癌に対してニボルマブ療法を行い、完全奏効に至った1例. 肺癌. 2019. 59. 3. 299-299
猿渡功一, 冨田雄介, 佐藤亮, 佐伯祥, 一安秀範, 藤井一彦, 坂上拓郎, 高松孝太郎, 中根俊成. 無症候性抗アセチルコリンレセプター抗体陽性非小細胞肺癌に対してニボルマブ療法を行い、完全奏効に至った1例. 肺癌. 2019. 59. 3. 299-299
御任玲美, 猿渡功一, 後藤由比古, 玉野井大介, 冨田雄介, 佐伯祥, 中村和芳, 岡本真一郎, 一安秀範, 藤井一彦, et al. 非小細胞肺癌におけるPD-1阻害薬の治療効果に対するステロイドの影響. 日本呼吸器学会誌. 2019. 8. 増刊. 206-206

ｍore...

Books (7)：

消化器疾患と腸内細菌叢の関わり-臨床的意義と治療への影響- 免疫チェックポイント阻害薬治療の有効性とプロバイオティクス
Progress in medicine 2022
HLA拘束性T細胞を誘導可能な末梢血モノサイト由来樹状細胞の大量産生法の開発
日本組織適合性学会 2015
CTLとTh1細胞を同時に活性化できるがん抗原ペプチドワクチン療法の開発
(株)メディカルレビュー社 2014
HLA Revisited HLA多型を考慮したがん免疫療法の開発
(株)医薬ジャーナル社 2013
【がんの免疫制御-研究と臨床の最前線】効果的ながん免疫療法に必要な技術開発とその臨床応用【腫瘍抗原の同定とがんワクチン】 cDNAマイクロアレイ解析とHLAトランスジェニックマウスを利用した理想的な腫瘍抗原ペプチドワクチン療法の開発
医歯薬出版(株) 2013

ｍore...

Lectures and oral presentations (8)：

腸内細菌叢を標的とした肺癌の治療戦略
(第92回日本呼吸器学会・日本結核非結核性抗酸菌症学会九州支部春季学術講演会シンポジウム2 2024)
Targeting the gut microbiota to treat advanced lung cancer
(2023)
The Importance of Gut Bacteria in Cancer Immunotherapy
(2023)
Targeting the gut microbiota to treat advanced lung cancer
(2022)
Treatment strategy for lung cancer with ILA: Targeting the gut microbiota to treat advanced lung cancer
(2022)

ｍore...

Professional career (2)：

M.D.
Ph.D.

Awards (3)：

2016 - National Institute of Health (NIH) National Institute of Health (NIH) Fellows Award for Research Excellence (FARE) 2016. ♣ Development of a new circulating tumor cell platform and a third generation next-gen sequencing technique for the discovery of oncogenic androgen receptor splice variants driving castrate-resistant prostate cancer
2012 - Japanese Society for Histocompatibility and Immunogenetics ♣ Incentive award of The 21st Annual Meeting of the Japanese Society for Histocompatibility and Immunogenetics
2012 - ♣ Kyusyu branch meeting of the Japanese Respiratory Society ♣ Incentive award of The 69st Kyusyu branch meeting of the Japanese Respiratory Society

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page